Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase 3 study of SNA 001

Next Previous
X
Search
Trial Profile

Phase 3 study of SNA 001

Status: Recruiting
Phase of Trial: Phase III

Latest Information Update: 08 Dec 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs SNA 001 (Primary)
  • Indications Thyroid cancer
  • Focus Adverse reactions; Therapeutic Use

    • Most Recent Events

    • 08 Dec 2021 New trial record
    • 29 Apr 2020 According to a SmartNuclide Biopharma media release, first patient has been enrolled in April.
    • 12 Feb 2020 According to a SmartNuclide Biopharma media release, The experimental leader unit is Zhongshan Hospital Affiliated to Fudan Universityvand the main researcher is Professor Hongcheng Shi. The ethical approval of SNA001 was approved by the leader unit on 26th November 2019.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top